INPLASY202180090

A systematic review and network meta-analysis to evaluate efficacy and safety of immunotherapy in the first-line treatment of metastatic hepatocellular carcinoma

Keywords: Metastatic hepatocellular carcinoma (mHCC); anti‑angiogenic agent; immunotherapy; prognosis; meta-analysis.

Review Status: Ongoing